|
1
|
Riaz SP, Lüchtenborg M, Coupland VH,
Spicer J, Peake MD and Møller H: Trends in incidence of small cell
lung cancer and all lung cancer. Lung Cancer. 75:280–284. 2012.
View Article : Google Scholar
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Govindan R, Page N, Morgensztern D, Read
W, Tierney R, Vlahiotis A, Spitznagel EL and Piccirillo J: Changing
epidemiology of small-cell lung cancer in the United States over
the last 30 years: Analysis of the surveillance, epidemiologic, and
end results database. J Clin Oncol. 24:4539–4544. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kahnert K, Kauffmann-Guerrero D and Huber
RM: SCLC-state of the art and what does the future have in store?
Clin Lung Cancer. 17:325–333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lamson DW and Brignall MS: Antioxidants in
cancer therapy; their actions and interactions with oncologic
therapies. Altern Med Rev. 4:304–329. 1999.PubMed/NCBI
|
|
6
|
Yang CS, Chung JY, Yang G, Chhabra SK and
Lee MJ: Tea and tea polyphenols in cancer prevention. J Nutr.
130(Suppl 2): 472S–478S. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fujiki H: Green tea: Health benefits as
cancer preventive for humans. Chem Rec. 5:119–132. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Clark J and You M: Chemoprevention of lung
cancer by tea. Mol Nutr Food Res. 50:144–151. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Khan N and Mukhtar H: Dietary agents for
prevention and treatment of lung cancer. Cancer Lett. 359:155–164.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liang W, Binns CW, Jian L and Lee AH: Does
the consumption of green tea reduce the risk of lung cancer among
smokers? Evid Based Complement Alternat Med. 4:17–22. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu Y, Yao R, Yan Y, Wang Y, Hara Y, Lubet
RA and You M: A gene expression signature that can predict green
tea exposure and chemopreventive efficacy of lung cancer in mice.
Cancer Res. 66:1956–1963. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sadava D, Whitlock E and Kane SE: The
green tea polyphenol, epigallocatechin-3-gallate inhibits
telomerase and induces apoptosis in drug-resistant lung cancer
cells. Biochem Biophys Res Commun. 360:233–237. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hernández-García S, González V, Sanz E and
Pandiella A: Effect of oncoxin oral solution in HER2-overexpressing
breast cancer. Nutr Cancer. 67:1159–1169. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hollman PC, Feskens EJ and Katan MB: Tea
flavonols in cardiovascular disease and cancer epidemiology. Proc
Soc Exp Biol Med. 220:198–202. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu L, Hudgins WR, Shack S, Yin MQ and
Samid D: Cinnamic acid: A natural product with potential use in
cancer intervention. Int J Cancer. 62:345–350. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gomez EV, Perez YM, Sanchez HV, Forment
GR, Soler EA, Bertot LC, García AY, del Rosario Abreu Vazquez M and
Fabian LG: Antioxidant and immunomodulatory effects of Viusid in
patients with chronic hepatitis C. World J Gastroenterol.
16:2638–2647. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Al-Mahtab M, Akbar SM, Khan MS and Rahman
S: Increased survival of patients with end-stage hepatocellular
carcinoma due to intake of ONCOXIN®, a dietary
supplement. Indian J Cancer. 52:443–446. 2015. View Article : Google Scholar
|
|
18
|
Dayem Uddin MAI, Mahmood I, Ghosha AK and
Khatuns RA: Findings of the 3-month supportive treatment with
ocoxin solution beside the standard modalities of patients with
different neoplastic diseases. TAJ. 22:172–175. 2009.
|
|
19
|
Díaz-Rodríguez E, Hernández-García S, Sanz
E and Pandiella A: Antitumoral effect of ocoxin on acute myeloid
leukemia. Oncotarget. 7:6231–6242. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Díaz-Rodríguez E, El-Mallah AM, Sanz E and
Pandiella A: Antitumoral effect of Ocoxin in hepatocellular
carcinoma. Oncol Lett. 14:1950–1958. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huqun EY, Endo Y, Xin H, Takahashi M,
Nukiwa T and Hagiwara K: A naturally occurring p73 mutation in a
p73-p53 double-mutant lung cancer cell line encodes p73 alpha
protein with a dominant-negative function. Cancer Sci. 94:718–724.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Postmus PE, de Ley L, van der Veen AY,
Mesander G, Buys CH and Elema JD: Two small cell lung cancer cell
lines established from rigid bronchoscope biopsies. Eur J Cancer
Clin Oncol. 24:753–763. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sher E, Pandiella A and Clementi F:
Voltage-operated calcium channels in small cell lung carcinoma cell
lines: Pharmacological, functional, and immunological properties.
Cancer Res. 50:3892–3896. 1990.PubMed/NCBI
|
|
24
|
Cabrera N, Díaz-Rodríguez E, Becker E,
Martín-Zanca D and Pandiella A: TrkA receptor ectodomain cleavage
generates a tyrosine-phosphorylated cell-associated fragment. J
Cell Biol. 132:427–436. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Folkman J: Angiogenesis in cancer,
vascular, rheumatoid and other disease. Nat Med. 1:27–31. 1995.
View Article : Google Scholar : PubMed/NCBI
|
